Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

"FDA remains committed to facilitating the development and approval of additional safe and effective therapies for adults with obesity or overweight." Experts have called the drug a "game changer ...

The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes drug ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

The drug, amycretin, is a peptide designed to ... the main pharmaceutical ingredient in the company’s approved obesity med Wegovy, with another engineered peptide called cagrilintide.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...